⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OVID News
Ovid Therapeutics Inc. Common Stock
Form 8-K
sec.gov
OVID
CERO
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
globenewswire.com
OVID
BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum
globenewswire.com
OVID
Form 8-K
sec.gov
OVID
Ovid Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
OVID
Form 8-K
sec.gov
OVID
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
globenewswire.com
OVID
Form 8-K
sec.gov
OVID
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
globenewswire.com
OVID
Form 8-K
sec.gov
OVID